Literature DB >> 27175269

Myeloid differentiation and the leukemia-initiating cell.

D G Tenen1.   

Abstract

Entities:  

Keywords:  AML-M2; C/EBPα; C/EBPα KO; HSC quiescence; Sox4; Sox4 KO; differentiation block

Year:  2014        PMID： 27175269      PMCID： PMC4851280          DOI： 10.1038/leusup.2014.14

Source DB:  PubMed          Journal:  Leuk Suppl        ISSN： 2044-5210


× No keyword cloud information.
  11 in total

1.  Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis.

Authors:  Yang Du; Sally E Spence; Nancy A Jenkins; Neal G Copeland
Journal:  Blood       Date:  2005-06-16       Impact factor: 22.113

2.  Generation of mice harboring a Sox4 conditional null allele.

Authors:  Alfredo Penzo-Méndez; Peter Dy; Bhattaram Pallavi; Véronique Lefebvre
Journal:  Genesis       Date:  2007-12       Impact factor: 2.487

3.  Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR.

Authors:  Kathryn E Boyd; Ying-Yi Xiao; Kai Fan; Amanda Poholek; Neal G Copeland; Nancy A Jenkins; Archibald S Perkins
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

4.  Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice.

Authors:  D E Zhang; P Zhang; N D Wang; C J Hetherington; G J Darlington; D G Tenen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

5.  Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.

Authors:  T Pabst; B U Mueller; P Zhang; H S Radomska; S Narravula; S Schnittger; G Behre; W Hiddemann; D G Tenen
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

6.  Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha.

Authors:  Pu Zhang; Junko Iwasaki-Arai; Hiromi Iwasaki; Maris L Fenyus; Tajhal Dayaram; Bronwyn M Owens; Hirokazu Shigematsu; Elena Levantini; Claudia S Huettner; Julie A Lekstrom-Himes; Koichi Akashi; Daniel G Tenen
Journal:  Immunity       Date:  2004-12       Impact factor: 31.745

7.  Prognostically useful gene-expression profiles in acute myeloid leukemia.

Authors:  Peter J M Valk; Roel G W Verhaak; M Antoinette Beijen; Claudia A J Erpelinck; Sahar Barjesteh van Waalwijk van Doorn-Khosrovani; Judith M Boer; H Berna Beverloo; Michael J Moorhouse; Peter J van der Spek; Bob Löwenberg; Ruud Delwel
Journal:  N Engl J Med       Date:  2004-04-15       Impact factor: 91.245

8.  Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C/EBPalpha mutant AML.

Authors:  Oxana Bereshchenko; Elena Mancini; Susan Moore; Daniel Bilbao; Robert Månsson; Sidinh Luc; Amit Grover; Sten Eirik W Jacobsen; David Bryder; Claus Nerlov
Journal:  Cancer Cell       Date:  2009-11-06       Impact factor: 31.743

9.  Sox4 is a key oncogenic target in C/EBPα mutant acute myeloid leukemia.

Authors:  Hong Zhang; Meritxell Alberich-Jorda; Giovanni Amabile; Henry Yang; Philipp B Staber; Annalisa Di Ruscio; Annalisa Diruscio; Robert S Welner; Alexander Ebralidze; Junyan Zhang; Elena Levantini; Véronique Lefebvre; Peter J M Valk; Ruud Delwel; Maarten Hoogenkamp; Claus Nerlov; Jörg Cammenga; Borja Saez; David T Scadden; Constanze Bonifer; Min Ye; Daniel G Tenen
Journal:  Cancer Cell       Date:  2013-10-31       Impact factor: 31.743

10.  C/EBPa controls acquisition and maintenance of adult haematopoietic stem cell quiescence.

Authors:  Min Ye; Hong Zhang; Giovanni Amabile; Henry Yang; Philipp B Staber; Pu Zhang; Elena Levantini; Meritxell Alberich-Jordà; Junyan Zhang; Akira Kawasaki; Daniel G Tenen
Journal:  Nat Cell Biol       Date:  2013-03-17       Impact factor: 28.824
View more
  1 in total

Review 1.  Molecular Mutations and Their Cooccurrences in Cytogenetically Normal Acute Myeloid Leukemia.

Authors:  Mengning Wang; Chuanwei Yang; Le Zhang; Dale G Schaar
Journal:  Stem Cells Int       Date:  2017-01-19       Impact factor: 5.443
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.